Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
JAMA Ophthalmology|February 29, 2024
ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) StudyMarco Nassisi, Giulia Coarelli, Benoit Blanchard, et al.
Nature Aging|February 11, 2026
Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's diseaseMelanie Shulman, Shuang Wu, Nick Ziogas, et al.
JAMA Neurology|October 30, 2023
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical TrialAmanda L Edwards, Jessica A Collins, Candice Junge, et al.
The New England Journal of Medicine|December 14, 2004
Rivastigmine for dementia associated with Parkinson's diseaseMurat Emre, Dag Aarsland, Alberto Albanese, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
Neurology|August 12, 2024
Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 CarriersGiulia Coarelli, Charlotte Dubec-Fleury, Emilien Petit, et al.
The New England Journal of Medicine|July 9, 2020
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALSTimothy Miller, Merit Cudkowicz, Pamela J Shaw, et al.
Lancet (London, England)|May 25, 2025
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case seriesNeil A Shneider, Matthew B Harms, Vlad A Korobeynikov, et al.
Nature Medicine|March 25, 2026
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trialOmar S Mabrouk, Ben Tichler, H Moore Arnold, et al.
Pageof 4